Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 9 | 2025 | 492 | 2.100 |
Why?
|
| Nanoparticles | 5 | 2025 | 293 | 1.730 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2130 | 1.010 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 224 | 0.870 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 51 | 0.630 |
Why?
|
| Prodrugs | 2 | 2020 | 56 | 0.620 |
Why?
|
| Coumarins | 2 | 2016 | 23 | 0.600 |
Why?
|
| Placenta | 4 | 2025 | 526 | 0.520 |
Why?
|
| Bibenzyls | 1 | 2016 | 1 | 0.480 |
Why?
|
| Naphthalenes | 1 | 2016 | 38 | 0.470 |
Why?
|
| Neoplasms | 3 | 2020 | 2968 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 3931 | 0.350 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1811 | 0.350 |
Why?
|
| Aorta | 2 | 2025 | 530 | 0.300 |
Why?
|
| Tubulin | 4 | 2020 | 75 | 0.300 |
Why?
|
| Animals | 15 | 2026 | 34262 | 0.280 |
Why?
|
| Immunotherapy | 2 | 2026 | 760 | 0.270 |
Why?
|
| Nanofibers | 1 | 2026 | 17 | 0.240 |
Why?
|
| Mice | 12 | 2026 | 18394 | 0.240 |
Why?
|
| Moyamoya Disease | 1 | 2025 | 43 | 0.220 |
Why?
|
| Particle Size | 1 | 2025 | 137 | 0.220 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 130 | 0.220 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 27 | 0.220 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4691 | 0.210 |
Why?
|
| Photons | 1 | 2025 | 64 | 0.210 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2025 | 186 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4733 | 0.200 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 874 | 0.200 |
Why?
|
| Actins | 1 | 2025 | 317 | 0.200 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2026 | 287 | 0.190 |
Why?
|
| Placenta Accreta | 1 | 2025 | 177 | 0.180 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 30 | 0.170 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 101 | 0.160 |
Why?
|
| Aortography | 1 | 2021 | 153 | 0.160 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 68 | 0.160 |
Why?
|
| Amyloid | 1 | 2020 | 76 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 36 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2021 | 114 | 0.150 |
Why?
|
| Solubility | 2 | 2018 | 117 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2020 | 102 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 214 | 0.150 |
Why?
|
| Fluorine | 1 | 2018 | 12 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 69 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 344 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2026 | 3703 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2016 | 580 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 555 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2015 | 11 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 703 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2016 | 76 | 0.110 |
Why?
|
| Water | 1 | 2016 | 189 | 0.110 |
Why?
|
| Drug Design | 1 | 2016 | 164 | 0.110 |
Why?
|
| Breast | 1 | 2016 | 217 | 0.110 |
Why?
|
| Benzocycloheptenes | 1 | 2013 | 1 | 0.100 |
Why?
|
| Amino Acids | 1 | 2016 | 572 | 0.100 |
Why?
|
| Humans | 10 | 2026 | 132041 | 0.090 |
Why?
|
| Pregnancy | 4 | 2025 | 7588 | 0.070 |
Why?
|
| Gadolinium | 2 | 2019 | 112 | 0.070 |
Why?
|
| Liposomes | 2 | 2019 | 201 | 0.070 |
Why?
|
| Female | 8 | 2026 | 71380 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2657 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 111 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2026 | 23 | 0.060 |
Why?
|
| Drug Liberation | 1 | 2026 | 43 | 0.060 |
Why?
|
| Polyesters | 1 | 2026 | 38 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2026 | 121 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2364 | 0.060 |
Why?
|
| Male | 4 | 2025 | 65425 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2026 | 148 | 0.060 |
Why?
|
| Niacinamide | 1 | 2025 | 30 | 0.060 |
Why?
|
| Polymerization | 2 | 2015 | 14 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2026 | 215 | 0.060 |
Why?
|
| Glycolysis | 1 | 2025 | 171 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1625 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2025 | 232 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 61 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 882 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2020 | 52 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 135 | 0.040 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2020 | 4 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 192 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 40 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 85 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 114 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 367 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 766 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 250 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 71 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 264 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 41 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 59 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 74 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 60 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 635 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 149 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1950 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 986 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 460 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 693 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3864 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 147 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2315 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1236 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2229 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3458 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 316 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3422 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6283 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2477 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17748 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 31747 | 0.010 |
Why?
|